` 688185 (CanSino Biologics Inc) vs Shanghai Composite Comparison - Alpha Spread

688185
vs
S
Shanghai Composite

Over the past 12 months, CanSino Biologics Inc has underperformed Shanghai Composite, delivering a return of +2% compared to the Shanghai Composite's +15% growth.

Stocks Performance
688185 vs Shanghai Composite

Loading
688185
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688185 vs Shanghai Composite

Loading
688185
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
688185 vs Shanghai Composite

Loading
688185
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
CanSino Biologics Inc vs Peers

Shanghai Composite
688185
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

CanSino Biologics Inc
Glance View

Market Cap
10.6B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
53.43 CNY
Overvaluation 18%
Intrinsic Value
Price
Back to Top